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The hypokinetic dysarthria observed in Parkinson’s disease (PD) aﬀects the range, speed, and accuracy of articulatory gestures
in patients, reducing the perceived quality of speech acoustic output in continuous speech. Deep brain stimulation (DBS) of the
subthalamic nucleus (STN-DBS) and of the caudal zona incerta (cZi-DBS) are current surgical treatment options for PD. This
study aimed at investigating the outcome of STN-DBS (7 patients) and cZi-DBS (7 patients) in two articulatory diadochokinesis
tasks(AMRandSMR)usingmeasurementsofarticulationrateandqualityoftheplosiveconsonants(usingthepercentmeasurable
VOT metric). The results indicate that patients receiving STN-DBS increased in articulation rate in the Stim-ON condition in the
AMR task only, with no eﬀect on production quality. Patients receiving cZi-DBS decreased in articulation rate in the Stim-ON
condition and further showed a reduction in production quality. The data therefore suggest that cZi-DBS is more detrimental for
extended articulatory movements than STN-DBS.
1.Introduction
Deep brain stimulation (DBS) in the subthalamic nucleus
(STN) is an established and eﬀective treatment for motor
symptoms associated with Parkinson’s disease (PD). How-
ever, eﬀects of STN-DBS on speech motor function are
varying, and minor improvements, as well as stimulation-
induced deterioration, have been reported [1–3]. This is also
the case regarding DBS in the nucleus ventralis intermedius
(Vim) of the thalamus, which is sometimes used for parkin-
sonian tremor, but most often for other forms of tremor
[4]. Recently, the Zona incerta (Zi) has been suggested as an
alternative target to the STN and Vim in PD [5, 6]. As part
of a larger study we have therefore decided to evaluate the
eﬀects of Zi-DBS on speech and to compare these with the
eﬀects of STN-DBS.
SpeechimpairmentisafrequentlyobservedfeatureofPD
[7]. The hypokinetic dysarthria associated with PD involves
reduction in movement range in articulatory gestures [8]
and, in contrast to both ataxic and spastic dysarthria, a
normal [9] or indeed accelerated voluntary articulation rate
[10, 11] in simple connected speech tasks. In the limited
time frame available during connected speech, the active
articulator often fails to reach the target location, resulting
in reduced perceptual quality in the resulting speech signal.
Frequently used experimental tasks in controlled studies
of speech production proﬁciency involve the production of
repeated syllables in a fast rate (diadochokinesis, DDK).2 Parkinson’s Disease
The task is administered either in the form of repeated
/pa/, /ta/, or /ka/ syllables (alternating motion rate, AMR)
or the repetitive production of the full sequence /pataka/
(sequential motion rate, SMR) [12]. In the ﬁrst form (AMR)
the speech articulation task measures the maximum rate in
articulatorymovementinthejawcombinedwithmovements
in the lips or anterior or posterior parts of the tongue [12].
As such, the AMR task estimates the maximum articulation
rate of syllable-sized units involving maximally extended
articulatory movements in the syllable onset.
Incontrast,theSMRtaskinvolvesanalternationbetween
places of constriction in the vocal tract, placing a higher
loadonpatients’sequencingofarticulatorymovements[12].
Thus, although not aimed at serving as proxies for patients’
production of ﬂuent speech [13], the two DDK tasks are
well suited to investigate eﬀects in patients’ articulatory
proﬁciency and control.
SpeciﬁcallyforpatientswithPD,TjadenandWatling[13]
argued that the AMR and SMR tasks provide a complemen-
tary description of articulatory proﬁciency in the patients
compared to normal controls. For the AMR task, results
have shown that PD patients may have a higher articulation
rate compared to healthy controls [10, 13] demonstrating
that PD patients are able to manifest continuous articulatory
alternations of even higher frequency than normal controls
performing the same simple task. In the more complex SMR
task, however, PD patients have shown a slowed articulation
rate compared to normal controls [13]. Thus, it is likely
that the relationship between speech articulation ability in
P Dp a t i e n t st ot h a to fn o r m a lc o n t r o l si sd e p e n d e n to n
the demands of the articulation task and consequently that
articulation rate in PD patients is best evaluated using both
AMR and SMR tasks [13].
A high articulation rate does not, however, necessarily
indicate an increased articulatory proﬁciency. It has been
proposed that an alternative way of achieving an increase in
articulation rate is by increasing the articulatory undershoot
in speech gestures, a feature that has been observed in PD
patients’speech[8,14,15].Patientswouldbeabletoincrease
the number of CV alternations per second by approximating
the full articulatory target (articulatory undershoot), at the
expense of acoustic quality.
The plosive group of consonant speech sounds has been
identiﬁedasparticularlysensitivetotheeﬀectsofarticulatory
undershoot [16]. In order for a plosive to be perceived, a
silent interval followed by an acoustic transient is a required
feature of the acoustic output. In order for this acoustic
output to be produced, a full closure between the active and
the passive articulator is required. After a period of pressure
build-up driven by the lungs, the plosive is released, creating
an instantaneous drop in pressure and resulting in the
acoustic transient [17]. Thus, due to its strong dependence
on a full range of motor action of the active articulator and
a continued full closure between the articulators during the
build-up of supraglottal pressure, the hypokinetic dysarthria
associated with PD is very likely to have strong negative
impact on the consonant produced, possibly failing to
produceastopconsonantatall.Inaprevocalposition,where
phonation is expected to follow the release of the plosive,
an interaction between subglottal and supraglottal pressure
may either aﬀord or prevent phonation to occur due to
the coordination of the articulatory movements involved,
placing further demands on the articulatory control of the
speaker.
The acoustic measure of Voice Onset Time (VOT) has
successfully been employed as a yardstick for an acceptable
plosive produced in prevocalic position [18]. VOT has been
deﬁned as the distance in time between the acoustic release
of the plosive and the onset of voicing of the following vowel
[19]. Thus, the measure requires both the presence of a
detectable acoustic transient and an onset of voicing in order
to be calculated.
V O Tv a l u e sh a v eb e e ns h o w nt ob ed i ﬃcult to measure
reliably across raters in PD patients [20]. Possibly due to
this fact, studies of VOT diﬀerences between PD patients
and normal speakers have produced variable results, where
PD patients were found to have a longer VOT [21], shorter
VOT [22], or no signiﬁcant diﬀerence [23, 24]c o m p a r e d
to normal geriatric controls. Thus, the VOT measure itself
has not provided conclusive results concerning the super-
and supra-laryngeal control and coordination in PD patients
due to the diﬃculty involved in making the acoustic
measurements. However, it has been argued by ¨ Ozsancak
et al. [25] that a more simple judgment of whether a VOT
measurement could be made or not may provide a more
suitable quantiﬁcation of this aspect of speech production
in dysarthric patients [25]. ¨ Ozsancak et al. [25] argued
that the relative frequency of which VOT measurements
are aﬀorded by the produced plosives correlates with the
articulatory control and precision in the patient: a positive
speech outcome in the disease is argued to lead to an increase
in percent measurable VOT. In addition, ¨ Ozsancak et al. [25]
found positive correlation between measurability of VOT
and Intelligibility Scores in dysarthric patients. Thus, the
measure is taken to provide a productive quantiﬁcation of
speech motor eﬀects due to the progression of the disease.
DBS is an established treatment for patients with PD
and has been shown to reduce cardinal symptoms of PD
related to motor function and control [26, 27]. For speech
motor proﬁciency, however, the results are more mixed.
In studies including the uniﬁed Parkinson’s disease rating
scale (UPDRS) [28] patients have been reported to show a
positive eﬀect on speech motor scores [29, 30], a diﬀerential
progression in DBS-STN eﬀect due stimulation parameters
[31], or a short-term positive eﬀect seen in 6-month [32, 33]
and 1–3-year followups [33, 34], which may disappear later
in the progression of the disease [26, 33]. Negative eﬀects of
DBS-STN on speech-related UPDRS motor scores (UPDRS-
III) have been found both in patients treated with unilateral
left hemisphere [35, 36], as well as bilateral stimulation
[2, 37, 38].
More detailed investigations have been conducted con-
cerning the nature of speech-related eﬀects of STN-DBS.
Positive outcomes have been shown in some studies for
voice parameters such as mean pitch [39, 40], pitch range
[39], and various measures of voice loudness and stability
[39–41]. Patients have also been shown to improve in force
in articulators in isolated motor tasks [42, 43] and inParkinson’s Disease 3
the variability of laryngeal and supraglottal coordination
timing [39] due to STN-DBS. Other studies have reported
a signiﬁcant positive eﬀect on voice intensity and pitch
variability when combined with L-dopa treatment [41], but
no eﬀect of STN-DBS alone.
STN-DBShashoweveralsobeenproposedtohavestrong
adverse eﬀects on speech production proﬁciency. Several
investigations have found stimulation-induced worsening in
speech articulation primarily in bilateral STN stimulation
[44, 45] or for patients stimulated unilaterally in the left
hemisphere [35, 36]. Thus, despite the positive eﬀects
achieved by stimulation on general motor proﬁciency [26],
speciﬁc features of speech articulation may be worsened in
patients stimulated in STN.
The STN is, however, not the only target in DBS for PD.
Recently, a nonrandomized study demonstrated the caudal
zona incerta (cZi) to be a more eﬃcient target regarding
UPDRS-III than the STN [5]. The cZi target was also
described by Plaha et al. [5] as not having the adverse eﬀects
on speech and balance as other areas closer to the STN. The
cZimightthereforebeconsideredapromisingtargetforDBS
i nt e r m so fs p e e c ho u t c o m e s .
The aim of the present study was to investigate the
articulatory proﬁciency in terms of articulation rate and
accuracy in a syllable repetition task in PD patients treated
with cZi-DBS compared to patients treated with STN-DBS.
2. Method
2.1. Patients. Fourteen consecutive patients (10 males and
4 females, aged between 49 and 72 years) with idiopathic
PD were included in this prospective nonrandomized study.
The patients had been selected on clinical grounds for
DBS surgery. Thus they were not recruited into the current
study on the basis of their speech status. The patients
were operated on between 2005–2007 (STN group) and
2008-2009 (cZi group). The clinical selection criteria for
the patients’ suitability for surgery were the same for both
groups.
These patients also participated in an accompanying
study on the comparative eﬀects of cZi-DBS and STN-DBS
on voice intensity [46].
The surgical procedures for the respective targets have
been previously described in detail [4, 5]. Seven consecutive
patients were implanted bilaterally (5) or unilaterally (left)
(2) in the STN, followed by seven implanted bilaterally in
the cZi. An overview of patients is presented in Table 1.T h e
study has been approved by the Regional Ethical Review
Board in Ume˚ a (Dnr: 08-093M; 2008-08-18).
2.2. Surgical Procedure. Targets and trajectories were iden-
tiﬁed on MRI using the Frame Link planning station
(Medtronic, Minneapolis, MN, USA). In the STN the target
was chosen at a line connecting the anterior borders of
the red nucleuses, at the level of their maximal diameter,
1.5mm lateral of the medial border of the STN. The target
in the posterior subthalamic area (PSA) was chosen at the
same level and slightly posteriorly medially to the STN
[11]. The electrode implantation was performed in local
anesthesia, and the eﬀect was evaluated using macrostim-
ulation. A stereotactic CT was performed during surgery,
and the images were fused with the preoperative MRI for
identiﬁcation of the electrode position.
2.3. Speech Samples. The speech material was selected from
recordings made in three clinical conditions: at baseline
before surgery where the patient was medicated with a
levodopa test dose equivalent to 1.5 times their normal
levodopa dosage, and then Oﬀ a n dO ns t i m u l a t i o n( o n e
hour after the stimulation was switched oﬀ and on, resp.)
12 months after surgery. The postoperative recordings were
made within the optimal period of the patient’s normal
medication cycle.
The recordings were made in a sound-treated booth,
using a calibrated head-mounted microphone (Sennheiser
MKE 2 P-C), with a 15cm mouth to microphone distance.
The samples were recorded on a digital audio ﬂash recorder
(Marantz PMD 660) or in the case of some early recordings
a digital audio tape recorder (Panasonic SV 3800). A
calibration tone (80dB, 1kHz) was used at the beginning of
each recording.
The speech material used in this study consisted of a
syllable repetition task. In the early recordings the patients
were instructed to repeat each syllable /pa/, /ta/, and /ka/
as fast and for as long as they could. In the more recent
recordings, the instructions were reﬁned so that the patients
weregivenmorespeciﬁcinformationwithanauditorymodel
of the task, and they ﬁrst practiced by repeating the syllables
evenly at normal tempo, before proceeding to their fastest
possible even tempo. This reﬁnement in instructions was
made in collaboration with other research centers in Sweden
to ensure comparability of speech data collected from PD
patients. Five STN patients received the earlier instructions
in all testing conditions, and six cZi patients received the
reﬁned instructions in all conditions. The remaining two
STN and one cZi patients received the earlier instructions
for the preoperative test and the reﬁned instructions for the
postoperative tests. The procedure was performed in two
sequences, ﬁrst using sequences of identical syllables /pa/,
/ta/, and /ka/ (AMR) and then again using a basic pattern
/pataka/ which was then repeated in the same way (SMR).
2.4. Acoustic Analysis. A l ls p e e c hm e a s u r e m e n t sw e r em a d e
from the display of the acoustic waveform presented by
the Wavesurfer (version 1.8.5) software package [47]. The
measurements were performed by the second and third
authors in a random order in terms of patient and treatment
condition in order to reduce the possibility of systematic
measurement eﬀects across patients. All syllable sequences
were examined to determine their suitability for inclusion.
The criterion for inclusion of a sequence was that it must
have consisted of at least 6 syllables (AMR) or 4 syllables
(SMR), where a syllable was deﬁned as measurable if it
consisted of an increase of energy followed by a period of
silence or reduced energy in the waveform [13]. In the AMR
productions, acoustic measurements of syllable duration4 Parkinson’s Disease
Table 1: Characteristics of patients in the two surgical groups. Mean age as well as median uniﬁed Parkinson’s disease rating scale smotor
scores, UPDRS-III, (with standard deviations) are provided. There were no statistical diﬀerences between the groups for age, duration since
diagnosis, or any of the UPDRS-III scores.
Characteristic STN group (n = 7) cZI group (n = 7)
Age (y) 62.2 ± 8.2 (51–72) 61.9 ± 9.0 (49–71)
Gender 5M,2F 5M,2F
Electrode placement 5 bilatera l,2 unilateral (left side) 7 bilateral
Duration since diagnosis 6.4 ± 1.5 (4–8) 5.6 ± 2.5 (2–10)
UPDRS III Oﬀ medication 39.0 (32–57) 31.0 (29–50)
UPDRS-III On medication 18.0 (6–36) 16.0 (10–42)
Speech∗ (UPDRS III Item 18) Oﬀ med 1.0 (0–2) 1.0 (0–2)
Speech (UPDRS III Item 18) On med 0.0 (0-1) 0.7 ± 0.5 (0–1)
were collected for syllable repetition 2–11 (10 syllables) or as
many syllables the patient was able to produce (a minimum
of 6). The ﬁrst syllable was excluded because the initial silent
closure phase in plosives in word-initial position makes it
not comparable to medial and ﬁnal plosives in terms of
measurable duration. Articulation speed was then estimated
bythetotaldurationofthemeasuredsequencedividedbythe
number of syllables in the sequence (syllables/s). Landmarks
for VOT measurements (release transient and voicing onset
[19]) were also identiﬁed and their combined presence in
the signals noted as VOT being measurable (both features
present) or not measurable. Syllables where either a release
transientorvoicingonsetwasnotpresentweremarkedasnot
measurable. Continuously voiced plosives were also marked
as it signiﬁes a lack of control in laryngeal functioning,
resultinginanonplosive(anapproximantofvoicedfricative)
being produced. The percent measurable VOT metric was
then calculated as the number of syllables meeting the VOT
criteria, divided by the total number of syllables in the
sequence, expressed as a percentage.
In the SMR material, the full /pataka/ production se-
quencesweremeasuredintermsoftheirduration,discarding
the ﬁrst sequence due to the eﬀect of the utterance-initial
silent phase. Up to 10 full sequences were measured if
present. A minimum of 4 full sequences was set as a lower
limit for inclusion of the sequence in the data set in order to
ensure that each mean estimate was based on at least three
points of data. Similar to the AMR productions, articulation
speed was estimated by the total duration of the measured
sequence divided by the number of syllables in the sequence
(syllables/s). In addition, VOT landmarks were identiﬁed for
the (up to 30) produced syllables in the selected production
sequences and their combined presence in the signals noted
as VOT being measurable or not measurable. As in the AMR
data, continuously voiced plosives resulted in the plosive
being judged as not measurable, as VOT is not deﬁned for
thisproductionpattern.ThepercentmeasurableVOTmetric
was then calculated as for AMR.
2.5. Reliability. The measurements of relative frequency of
measurable VOT and speech rate were repeated for 10%
of the samples by two independent raters (the second and
third author) in order to estimate the interrater agreement.
The exact agreement in ratings of measurability of VOT was
established at 93.8% (κ = 0.87). Diﬀerences in estimates of
speech rates were within 0.047 syllables/s in 75% of the cases,
within 0.21 syllables/s in 83.3% of the cases, and within 0.69
syllables/s in 100% of the cases.
2.6. Statistical Analysis. Between-within (2 × 3) analyses of
variance were conducted to test for statistical signiﬁcance
of diﬀerences in articulation rate and degree of measurable
VOT related to stimulation target (STN versus cZI) and
recording condition (baseline, Stim On, and Stim Oﬀ)a s
well as interactions between these variables. Within the data
collected during the AMR speech task, eﬀects of syllable type
(/pa/,/ta/,or/ka/)wereincludedintheanalysisina2 ×3 ×3
ANOVA. The relationship between articulation rate and the
relative frequency of measurable VOT was investigated using
linear regression models.
3. Results
3.1. Articulation Rate. The articulation rates in the AMR and
SMR tasks were analyzed for treatment eﬀects separately for
cZi and STN patients On and Oﬀ stimulation compared
to baseline. The results are presented in Figure 1,d i v i d e d
according to articulation task (AMR or SMR), stimulation
condition (baseline, Stim OFF, or Stim ON), and stimulated
target (STN or cZi). Within the AMR data, separate analysis
was performed for the diﬀerent syllable types (/pa/, /ta/, and
/ka/) produced by the patients.
For the STN patients, mean number of syllables per
second increased from 5.13 to 5.54 in the AMR task, but
remained at 5.63 in the SMR task. In the cZi patients, the
results from the AMR task showed a decrease in number of
syllables produced per second Stim ON compared to Stim
OFF. In the SMR task, the number of syllables per second
decreased from 4.90 in Stim OFF to 4.70 in Stim ON. In
the AMR task, STN-DBS stimulation increased the mean
articulation rate for all syllable types (5.05 to 5.85 for /p/,
5.06 to 5.44 for /pa/, and 4.99 to 5.32 for /ka/). The cZi-DBS
group results were more mixed (4.95 to 5.25 for /p/, 4.95 to
4.72 for /pa/, and 4.87 to 4.53 for /ka/).
The articulation rates in the two tasks and three
stimulation conditions were tested using a 2 × 3 × 3Parkinson’s Disease 5
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Figure 1: Box plot showing articulation rate under the three stimulation conditions for the two investigated patient groups and speech tasks.
ANOVA, with condition and task interaction included.
The results showed a signiﬁcant main eﬀect of stimulation
condition (F(2,96) = 5.98, P = 0.003) and of stimulated
target (F(2,96) = 5.35, P = 0.02), but no signiﬁcant main
eﬀect or interaction eﬀect involving syllable type. A Tukey
“Honest Signiﬁcant Diﬀerences” post hoc test conﬁrmed
the signiﬁcant increase in articulation rate in the AMR task
due to STN stimulation (F(2,96) = 5.84, P = 0.004) and the
overall (task independent) reduced articulation rate in cZi
c o m p a r e dt oS T NS t i mO N( F(2,96) = 5.84, P = 0.024) but no
other investigated contrast.
A separate analysis into articulation rate eﬀect in
the bilaterally and unilaterally operated STN-DBS patients
showed no systematic eﬀect of laterality. The two patients
treated with unilateral (left) stimulation showed tentative
signs of opposite treatment eﬀects. Further, for each of
these observed eﬀects, a similar eﬀect in both size and
directioncouldbeobservedinatleastonebilateralSTN-DBS
patient. Thus, no support for a diﬀering eﬀect of bilateral
and unilateral (left) STN in terms of articulation rate was
provided by the present data.
3.2. Percent Measurable VOT. The quality of articulation was
estimated using the relative frequency of measurable VOT
metric, and the results are presented in Figure 2. For the STN
patients performing the AMR task, mean rate of measurable
VOT was 77.7% in Stim OFF and was reduced to 65.8% in
Stim ON. In the SMR task, 76.6% of the syllables contained
the necessary criteria for VOT measurement in Stim OFF,
compared to a mean rate of 73.4% in Stim ON.
For the cZi patients, 81.0% of the productions were
measurableintheAMRtaskunderStimOFF,butonly51.0%6 Parkinson’s Disease
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Figure 2:RelativefrequencyofmeasurableVOTinplosivesproducedunderthethreestimulationconditionsforthetwoinvestigatedpatient
g r o u p sa n ds p e e c ht a s k s .
in Stim ON. In the SMR task, the patients performed worse
compared to the AMR task (63.5% in Stim OFF), which was
then reduced to a value similar to the AMR task in Stim ON
(55.3%).
Statistical testing using a 2 × 3 × 3A N O V Aw i t ha r t i c -
ulation task, stimulation condition, stimulated target, and
syllable type (including interactions) showed a signiﬁcant
main eﬀect of stimulation condition (F(2,72) = 7.9, P < 0.001)
only. A Tukey “Honest Signiﬁcant Diﬀerences” post hoc test
conﬁrmed the signiﬁcant reduction in rate of measurable
VOT in cZi patients (F(2,72) = 3.72, P = 0.037), but no other
investigated contrasts.
A separate analysis of diﬀerences between the bilaterally
and unilaterally operated STN-DBS patients showed no
systematic eﬀect of laterality. The two patients treated with
unilateral (left) stimulation showed a similar eﬀect in both
size and direction to what was observed for at least one
bilateral STN-DBS patient. Thus, no support for a diﬀering
eﬀect of bilateral and unilateral (left) STN in terms of
articulation data was provided by the present data.
3.3. Association between Articulation Rate and Percent Mea-
surable VOT. The association between articulation rate and
articulatory precision was investigated by the correlation
between the computed numbers of syllables per second
produced and the relative frequency of measurable VOT
values in the plosives produced using the Pearson’s product-
moment correlation coeﬃcient. The results showed aParkinson’s Disease 7
signiﬁcant (t(82) = −3.57, P < 0.001) negative overall
correlation between articulation rate and relative frequency
of measurable VOT (ρ = −0.37). A more detailed analysis of
correlations between measurements within cells created by
combinations of stimulation condition (baseline, Stim ON,
and Stim OFF) and stimulated target showed a signiﬁcant
correlation only in postsurgery conditions for cZi patients
(Stim ON: ρ = −0.60, t(12) = −2.59, P = 0.023; Stim OFF: ρ =
−0.604, t(12) = −2.63, P = 0.021). No signiﬁcant correlation
was found for STN patients.
The association between the two quantities was further
investigated using linear regression ﬁtted to the data within
cells created by combinations of stimulation condition and
target where a signiﬁcant correlation had been shown. The
regression line ﬁtted to the data showed a slope of −0.010
(SE(slope) = 0.0038) for Stim OFF (adjusted R2 = 0.313) and
−0.014 (SE(slope) = 0.0054) for Stim ON (adjusted R2 =
0.306). Thus, a clear impact of an increase in articulation
rate on articulatory precision was observed. As the standard
errors of the slope estimates overlap almost completely,
the association between articulation rate and articulatory
precision (as measured by relative frequency of measurable
VOT) was considered equal between postsurgery conditions
for the cZi patient group.
The eﬀect of the reﬁnement of instructions given to
the patients was evaluated using Welch two-sample t-tests
comparing the articulation rate in patients receiving an
auditorymodelandpatientsnotreceivinganauditorymodel
in the baseline recordings, for each task and repeated syllable
separately. The results showed no eﬀect of the auditory
model (t(11.05) = −1.4373, P = 0.18 for /pa/, t(11.77) = −1.7843,
P = 0.10 for /ta/, t(11.87) = −0.9014, P = 0.38 for /k/,
and t(8.08) = −0.6301, P = 0.54 for /pataka/) between the
groups. Further, no indication of an eﬀect of instruction
modiﬁcation was perceived within the treatment groups:
patients receiving the other set of instructions (earlier or
reﬁned depending on treatment group) did not make up
extremes within the groups, and for each of these patients
a comparable patient in terms of mean and variation in
articulation rates could be observed in the data set. Thus, the
results reported here did not show evidence of a systematic
eﬀect of the reﬁnement in instructions given for the tasks.
4. Discussion
The present aim was to investigate and compare the speech
production rate and accuracy in patients treated with STN
and cZi DBS, as quantiﬁed by mean number of syllables per
second and relative frequency of measurable VOT in plosive
consonants [25]. Two speech tasks were investigated, the
AMR task and the more complex SMR task.
The results indicate an increase in articulation rate in
STN patients performing the AMR task in the stimulated
condition and a decrease in articulation rate in cZi in
the same condition, regardless of task performed. At Oﬀ
stimulation the patients did not perform signiﬁcantly dif-
ferently compared to the presurgery baseline. Thus, the
results indicate a reduction in articulation rate due to cZi
stimulation and an (task dependent) increase in rate of
articulation due to STN stimulation.
Intermsofarticulatoryprecision,theSTNgroupappears
not to be signiﬁcantly aﬀected by stimulation. No signiﬁcant
diﬀerences were obtained between conditions or between
tasks for this group. For the cZi group, however, a signiﬁcant
decrease in relative frequency of measurable VOT was
observed in Stim ON. Thus, with stimulation turned on, cZi
patients showed signs of a signiﬁcant increase in articulatory
undershoot [48] and a reduction in the articulatory control
needed to achieve a plosive with the appropriate perceptual
characteristics.
The articulatory undershoot was also shown to be partly
dependent on the rate of articulation in the task, but only
signiﬁcantly so in speciﬁc conditions. In the postsurgery
recording for cZi patients, productions were signiﬁcantly
reduced in articulation quality with increase in articulation
rate. The linear regression applied indicated that an increase
in articulation rate with one syllable per second caused, on
average, a reduction in the relative frequency of measurable
VOT for the cZi group of 25 or 35 points on a percentage
scale. While the data to which the linear regression was
ﬁttedshowasubstantialvariation,witha0.306–0.31R2 value
for the ﬁt, the results show a signiﬁcant overall correlation
between the articulation rate and the production quality
which is attributed to a strong correlation between the two
quantities in the cZi patients in both Stim ON and Stim OFF.
Two of the patients in the STN-DBS were under
unilateral stimulation, while the other ﬁve patients were
bilateral patients. Lateralization eﬀects of STN-DBS on
various aspects of speech have been reported previously
[35, 49]. Wang et al. [49] showed a signiﬁcant increase in
syllable rate in STN-DBS (right) compared to STN-DBS
(left) patients. However, bilateral data was not provided by
Wang et al. The investigation by Santens et al. [35]p r o v i d e d
no acoustic measurements, but was based on perceptual
measurements. In their results, unilateral (left) STN-DBS
provided no signiﬁcant diﬀerences between judgments of
speech prosody, articulation, and intelligibility by trained
professionals compared to bilateral stimulation. Thus, in as
far as the articulation results from Santens et al. [35]a r e
comparabletothepercentmeasurableVOTmetricpresented
here, inclusion of unilateral patients is unlikely to have
aﬀected the outcomes of the present study. Furthermore, we
found that removing the unilateral patients from the data set
still aﬀorded the same conclusion and also for each one of
the two unilateral patients, a similar treatment eﬀect (both
in size and direction) could be observed in a bilateral STN-
DBS patient. We therefore feel assured that the unilateral
patients do not diﬀer signiﬁcantly from the bilateral patients
in (supraglottal) articulatory control, which seems to be in
agreement with the Santens et al. data [35].
ThemeasurementsofmeasurabilityofVOTandarticula-
tion rate were derived from the acoustic signal and were con-
ducted in a randomized procedure, but the experimenters
were blinded only to the treatment localization of the patient
and not to the stimulation condition. The lack of blinding of
the experimenters has the potential of being a confounding
factor in the results. However, the data presented here8 Parkinson’s Disease
were obtained directly from the physical properties of the
acoustic signal using speciﬁc criteria, and the measurements
were repeated with high level of interrater reliability. Thus,
the risk of the blinding factor inﬂuencing the results is
highly reduced due to the nature of the data. Further, the
results presented here involve interactions between the task
performed, stimulation condition (to which raters were not
blinded) and targeted localization (to which the raters were
blinded).Further,nocomparablespeechdatahadbeenmade
available in the literature for cZi patients at the time the
measurements were made. With a randomized procedure,
experimenters being blinded to at least one factor in the
signiﬁcant interactions and not having any information on
which to base expectations, the chance of the lack of blinding
being a confounding factor in the results presented here is
judgedtobeverysmall.Thus,weconcludedthattheblinding
ofexperimenterswasnotaconfoundingfactorinourresults.
Theinstructionsgiventothepatientswerereﬁnedinlater
recordings to include a practice run and an auditory model.
This reﬁnement was made to ensure comparability of our
data with data collected from PD patients in other centers
across Sweden. The impact of this potential confounding
factor was investigated for statistical diﬀerences in articu-
lation rate between patients receiving the two versions of
instructions. The results showed no evidence of a signiﬁcant
eﬀect of instructions in on the articulation rate in the speech
task, and no evidence was found for patients deviating from
the treatment group trend due to the instructions received.
Thus, it is concluded that the change in instructions given to
thepatientswasnotaconfoundingfactorinthepresentdata.
Our results suggest a diﬀerentiated treatment eﬀect of
STN and cZi stimulation in terms of articulatory proﬁciency
based on acoustic measurements. STN patients increased in
articulation rate (in the simple AMR task) ON stimulation,
while cZi patients decreased in articulation rate in both tasks
in the same condition. Further, the quality of production
decreased with cZi stimulation, but showed a much smaller
(and not signiﬁcant) eﬀect of stimulation in the STN.
These ﬁndings are in accordance with previous ﬁnd-
ings. Dysarthria is common in PD, and STN-DBS has
previously been reported to improve certain aspects of
speech in some patients [39–43]. Further, dysarthria in PD
in positron emission tomography (PET) studies has been
linked to an overactivation in the SMA and DLPFC and
an underactivation in the cerebellum and primary motor
cortex. A normalization of these changes by STN-DBS has
been demonstrated in one study in patients where STN-
DBS improved speech [45, 50]. Concerning deterioration of
speech following Zi-DBS, it has recently been demonstrated
that dysarthria in STN-DBS is more likely to be caused
by electrodes placed more medially in proximity to the
anterior Zi [2, 51], and dysarthria constituted a problem in
patients implanted in the anterior Zi [5]. This side eﬀect
is probably caused by an aﬀection of the cerebellothalamic
ﬁbers in the area. Aﬀection of these ﬁbers, passing into
the Vim, is probably also responsible for many cases of
dysarthria following Vim-DBS [51], which previously has
been attributed to a spread of current to the internal capsule
[52].
The acoustic results presented here have been interpreted
in terms of articulatory proﬁciency. The quantiﬁcation of
articulatory proﬁciency (measurability of VOT) was chosen
primarilybecauseitinvolvesacomplexcoordinationofartic-
ulatory gestures in the glottal and supraglottal structures,
and it has been used in previous research for dysarthric
speakers [25]. Additionally, DDK results and measurability
of VOT in particular have all been linked individually to
intelligibility of speech [25, 35, 53]. Furthermore, acoustic
measures are capable of detecting subperceptual speech
changes and are not subject to inﬂuences of auditory
perceptual bias [54]. The results from the current study
provide evidence of a direct eﬀect of STN-DBS or cZi-
DBS on the patients’ articulatory proﬁciency. As such, they
indicate advances and worsening in motor control and
proﬁciency in PD patients due to DBS-STN or DBS-cZi.
However, it is diﬃcult to evaluate the present results
in terms of a communicative setting (such as intelligibility
or comprehensibility of the speech produced). Perceived
articulatory precision in patients with PD, DDK results, and
measurability of VOT in particular have all been linked
individually to intelligibility of speech [25, 35, 53], but it is
also possible that the changes reported here are below the
perceptual threshold. It is beyond the aim and scope of this
paper to investigate perceptual eﬀects of observed changes
in the motor proﬁciency in the listener. The perceptual
impactofthetreatmenteﬀectsfoundhereshouldbetargeted
by further research using suitable speech material and
procedures that speciﬁcally address these issues.
5. Conclusion
This paper has provided evidence of a DBS-induced increase
in articulation rate in the AMR task for STN patients,
with no signiﬁcant negative eﬀect on production quality,
but a decrease in both articulate and production quality
across both tasks for cZi patients. A related study [46] that
used essentially the same patient groups has also shown a
diﬀerential response between cZi- and STN-DBS for voice
intensity. Thus, it is concluded that cZi stimulation might
be more detrimental for articulatory proﬁciency in patients
compared to stimulation of the STN. Our results must,
however, be interpreted with caution, as they are based on
a limited number of patients.
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